Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
If insurance won't cover it, drug makers offer savings programs that can bring the monthly cost down
They also decreased the expression of genes involved in cholesterol synthesis ( ACAT1 , SREBP-2 , HMGCR , and SQLE ), bile acid synthesis ( LXR and CYP7A1 ), and PCSK9 , while increasing the expression of genes involved in the reverse cholesterol transport pathway ( ABCA1 and SR-B1 ) and low-density lipoprotein cholesterol uptake ( LDLR )
File history You cannot overwrite this file
Technical Information Compound Name: Retatrutide Peptide Classification: Triple Hormone Receptor Agonist (GLP-1 / GIP / Glucagon Receptor Agonist) Molecular Formula: CHNO Appearance: White to off-white lyophilized powder Solubility: Typically soluble in bacteriostatic water or suitable research-grade diluents Research Category: Metabolic and multi-receptor pathway research peptide Common Research Areas GLP-1, GIP, and glucagon receptor signaling Glucose-homeostasis investigations Appetite and satiety-related research Adipose and energy-balance studies Metabolic and obesity-related investigations Cardiometabolic and endocrine-signaling pathways For Laboratory and Research Use Only Not for human consumption or therapeutic use
The squat is probably the single most valuable exercise in your arsenal
Not everyone with obesity needs a GLP-1 medication
